Physiologically-Based Pharmacokinetic Model of Sertraline in Human to Predict Clinical Relevance of Concentrations at Target Tissues
- 1 July 2020
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 108 (1), 136-144
- https://doi.org/10.1002/cpt.1824
Abstract
Significant in vitro and in vivo evidence supports the potential use of sertraline as an anticancer and antimicrobial agent. Yet, it is unknown whether effective sertraline concentrations are clinically achieved at therapeutic doses. The study objectives were to develop a physiologically-based pharmacokinetic (PBPK) model of sertraline and estimate the probability of achieving effective concentrations in various human tissues. A generic PBPK model consisting of perfusion-limited compartments representing the body organs linked together by blood flows and incorporated with clearance, tissue distribution, and absorption models was implemented in R using the mrgsolve package. Sertraline clearance and volume of distribution were first optimized from i.v. plasma concentration data then absorption and bioavailability were optimized from oral data. Predicted unbound sertraline concentrations at steady-state in human tissues did not reach concentrations determined in vitro, indicating therapeutic doses of sertraline are unlikely to produce concentrations required for anticancer and antimicrobial activities in humans.This publication has 47 references indexed in Scilit:
- Cross‐species discovery of syncretic drug combinations that potentiate the antifungal fluconazoleMolecular Systems Biology, 2011
- Effects of sertraline hydrochloride and fluconazole combinations onCryptococcus neoformansandCryptococcus gattiiMycology, 2010
- The use of gastrointestinal intubation studies for controlled release developmentBritish Journal of Clinical Pharmacology, 2009
- Role of Physiological Intestinal Water in Oral AbsorptionThe AAPS Journal, 2009
- Defeating Cancer With Antidepressantsecancermedicalscience, 2008
- Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Lineshape AnalysisClinical Pharmacokinetics, 2008
- Misuse of the Well-Stirred Model of Hepatic Drug Clearance: Fig. 1.Drug Metabolism and Disposition, 2007
- Clinical Pharmacokinetics of SertralineClinical Pharmacokinetics, 2002
- Metabolism and disposition of luminol in the ratXenobiotica, 2000
- Pharmacokinetics of Sertraline and its N-Demethyl Metabolite in Elderly and Young Male and Female VolunteersClinical Pharmacokinetics, 1997